L. Nielsen (Aarhus, Denmark), G. Folkerts (Utrecht, The Netherlands)
Pharmacology of airway smooth muscle and cell influx in a murine asthma model S. Fernandez-Rodriguez, K. J. Broadley, E. J. Kidd (Cardiff, United Kingdom)
| |
The PAR2-activating peptide SLIGRL inhibits airway hyper-responsiveness and eosinophilia in an acute murine model of allergic asthma B. A. Decampo, R. G. Goldie, P. J. Rigby, P. J. Henry (Perth, Australia)
| |
Dose-dependent effects of muIL-13Rα2, a potent IL-13 neutraliser, on the phenotype of an acute allergic airways inflammation model in BALB/c mice R. D. May, P. D. Monk, J. Woods, I. K. Anderson (Cambridge, United Kingdom)
| |
Roflumilast inhibits chemokine release in animal models of COPD and asthma L. Wollin, D. S. Bundschuh, D. Marx, A. Wohlsen, R. Beume (Konstanz, Germany)
| |
Allergen-induced airway decorin production is inhibited by budesonide and formoterol in a mouse model of asthma L. Uller, K. Rydell, G. Westergren-Thorsson, J. S. Erjefält, C. G. Persson, A. Miller-Larsson (Lund, Sweden)
| |
Impact of symbicort® on established airway inflammation and remodeling in mice chronically exposed to house dust mite extract J. Johnson, J. Wong, S. Eirefelt, A. Miller-Larsson, M. Jordana (Hamilton, Canada; Lund, Sweden)
| |
Chronic nitric oxide inhibition increases airway remodeling in guinea pigs with lung inflammation C. M. Prado, E. A. Leick-Maldonado, D. I. Kasahara, M. A. Martins, V. L. Capelozzi, I. F. L. C. Tibério (São Paulo, Brazil)
| |
Involvement of neuropeptide and muscarinic receptor in pulmonary obstruction induced by cigarette smoke in mice T. Kishi, K. Fukuchi, T. Yasue (Tochigi, Japan)
| |